The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 03, 2012
Filed:
Apr. 25, 2006
Younes Bekkali, Danbury, CT (US);
Rajashehar Betageri, Bethel, CT (US);
Mario G. Cardozo, San Francisco, CA (US);
Thomas A. Gilmore, Salem, MA (US);
Christian Hanke Justus Joachim Harcken, New Milford, CT (US);
Thomas Martin Kirrane, Danbury, CT (US);
Daniel Kuzmich, Danbury, CT (US);
John Robert Proudfoot, Newtown, CT (US);
Doris Riether, New York, NY (US);
Hidenori Takahashi, LaGrangeville, NY (US);
David S. Thomson, Ridgefield, CT (US);
Ji Wang, Amherst, MA (US);
Renee M. Zindell, New Milford, CT (US);
Hossein Razavi, Danbury, CT (US);
Younes Bekkali, Danbury, CT (US);
Rajashehar Betageri, Bethel, CT (US);
Mario G. Cardozo, San Francisco, CA (US);
Thomas A. Gilmore, Salem, MA (US);
Christian Hanke Justus Joachim Harcken, New Milford, CT (US);
Thomas Martin Kirrane, Danbury, CT (US);
Daniel Kuzmich, Danbury, CT (US);
John Robert Proudfoot, Newtown, CT (US);
Doris Riether, New York, NY (US);
Hidenori Takahashi, LaGrangeville, NY (US);
David S. Thomson, Ridgefield, CT (US);
Ji Wang, Amherst, MA (US);
Renee M. Zindell, New Milford, CT (US);
Hossein Razavi, Danbury, CT (US);
Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT (US);
Abstract
Compounds of Formula (IA) wherein R, R, R, Rand Rare as defined herein for Formula (IA), or a tautomer, prodrug, solvate, or salt thereof; pharmaceutical compositions containing such compounds, and methods of modulating the glucocorticoid receptor function and methods of treating disease-states or conditions mediated by the glucocorticoid receptor function or characterized by inflammatory, allergic, or proliferative processes in a patient using these compounds.